Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21577393 | 0.82 | — | — | |
| Decanoic Acid SCHEMBL20471382 | 0.81 | GPR84 (0.49) | — | |
| SCHEMBL631049 | 0.80 | CYP2C19 (0.38) | CCR2 | |
| SCHEMBL9247025 | 0.80 | CCR2 (0.33) | CCR2 | |
| SCHEMBL28971652 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL1002860 | 0.80 | ALDH1A1 (0.32) | — | |
| SCHEMBL4453702 | 0.79 | CCR2 (0.36) | CCR2 | |
| SCHEMBL8383255 | 0.78 | — | — | |
| SCHEMBL8374615 | 0.78 | KDM4E (0.31) | — | |
| SCHEMBL7196375 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6852852-B2 | Method of producing regioselectively substituted esters of oligo- and polysaccharides | WOLFF WALSRODE AG (DE) | 2005-02-08 | — | — | US | disclosed |
| US-20030162745-A1 | Method of producing regioselectively substituted esters of oligo- and polysaccharides | DOW GLOBAL TECHNOLOGIES INC. | 2003-08-28 | — | — | US | disclosed |
| US-6489468-B1 | REGIOSELECTIVELY SUBSTITUTED, PREDOMINANTLY AT THE C2 POSITION OF THE ANHYDROGLUCOSE UNIT (AGU); STARCH ESTERS | WOLFF WALSRODE AG (DE) | 2002-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162745-A1 | Method of producing regioselectively substituted esters of oligo- and polysaccharides | OSTC, SI, OGT | CCR2 2482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.